当前位置: 首页 > 期刊 > 《中国医学创新》 > 202013
编号:13480015
新生儿败血症的诊疗进展(5)
http://www.100md.com 2020年5月5日 《中国医学创新》 202013
     [27] Choo Y K,Cho H S,Seo I B,et al.Comparison of the accuracy of neutrophil CD64 and C-reactive protein as a single test for the early detection of neonatal sepsis[J].Korean Journal of Pediatrics,2012,55(1):11.

    [28] Murphy K,Weiner J.Use of leukocyte counts in evaluation of early-onset neonatal sepsis[J].Pediatr Infect Dis J,2012,31(1):16.

    [29] Pourcyrous M,Bada H S,Korones S B,et al.Significance of serial C-reactive protein responses in neonatal infection and other disorders[J].Pediatrics,1993,92(3):431.

    [30] Brown J V E,Meader N,Cleminson J,et al.C-reactive protein for diagnosing late-onset infection in newborn infants[J].Cochrane Database Syst Rev,2019,1:CD012126.

    [31] Maniaci V,Dauber A,Weiss S,et al.Procalcitonin in young febrile infants for the detection of serious bacterial infections[J].Pediatrics,2008,122(4):701.

    [32] Vouloumanou E K,Plessa E,Karageorgopoulos D E,et al.

    Serum procalcitonin as a diagnostic marker for neonatal sepsis:a systematic review and meta-analysis[J].Intensive Care Med,2011,37(5):747.

    [33] Hedegaard S S,Wisborg K,Hvas A M.Diagnostic utility of biomarkers for neonatal sepsis-a systematic review[J].Infect Dis(Lond),2015,47(3):117.

    (收稿日期:2019-11-06) (本文編辑:程旭然), 百拇医药(洪美婷 敖当)
上一页1 2 3 4 5